uti amc has scheduled a one-on-one meeting with Choice Institutional Equities for August 17, 2026, at 4:00 PM IST. The session will be held in person at the company’s corporate office in Bandra Kurla Complex (BKC), Mumbai. This engagement allows institutional investors to interact directly with senior management regarding the company’s performance and strategy, maintaining transparent communication channels.

The disclosure was made pursuant to Regulation 30 read with Schedule III Part A Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with relevant SEBI Circulars. UTI AMC notified both the National Stock Exchange of India Limited and BSE Limited of the schedule on August 11, 2026. The filing confirms that no Unpublished Price Sensitive Information (UPSI) will be shared during the interaction, ensuring adherence to insider trading regulations.

Meeting Schedule

The meeting is structured as a private, one-on-one interaction designed for focused discussions between asset managers and institutional stakeholders. The date remains subject to change as per standard exchange filing protocols.

Compliance and Disclosure Details

Arvind Patkar, Company Secretary and Compliance Officer of UTI AMC, signed the disclosure filing. The company continues to maintain strict compliance with information dissemination protocols, ensuring equitable access to information for all investors. This procedural update reflects the ongoing commitment to transparent communication with the investor base.

UTI Asset Management Company Limited will host a one-on-one analyst and institutional investor meeting with senior management from ICICI Prudential Asset Management Company Limited on August 6, 2026. The session is scheduled to begin at 15:00 IST and will be conducted in person at the corporate office in Bandra Kurla Complex, Mumbai. This engagement allows for direct dialogue between the two asset management entities regarding market developments and strategic outlooks, adhering to standard industry practices for investor relations.

The disclosure was made pursuant to Regulation 30 read with Schedule III Part A Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. UTI AMC also referenced relevant SEBI Circulars governing such interactions. The filing was signed by Arvind Patkar, the Company Secretary and Compliance Officer of UTI AMC, on July 31, 2026.

Meeting Details

The company emphasized that the meeting will be strictly one-on-one. It further clarified that no Unpublished Price Sensitive Information (UPSI) will be shared during the interaction. As per regulatory norms, any changes to the date or time of the meeting will be communicated subsequently if required.

Regulatory Compliance

UTI AMC’s disclosure aligns with the mandatory requirements for listed entities to inform stock exchanges about scheduled meetings with analysts and institutional investors. By notifying both the National Stock Exchange of India Limited and BSE Limited, the company ensures transparency in its investor communication processes. The meeting serves as a platform for discussing operational performance and market trends without disclosing material non-public information.

Arvind Patkar, holding Membership No. ACS 21577, certified the accuracy of the schedule. The intimation was filed on July 31, 2026, providing sufficient notice to the markets before the scheduled engagement on August 6, 2026.